Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China

被引:16
作者
Shen, Xiaolei [1 ]
Wang, Ping [1 ]
Shen, Jun [1 ]
Jiang, Yuhan [1 ]
Wu, Li [1 ]
Nie, Xin [2 ]
Liu, Jianren [1 ]
Chen, Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ Sch Med, Shanghai Peoples Hosp 9, Dept Neurol, Shanghai 200011, Peoples R China
[2] Shanghai Jiao Tong Univ Sch Med, Shanghai Peoples Hosp 9, Biostat Off Clin Res Unit, Shanghai 200011, Peoples R China
关键词
COVID-19; Omicron; Neurological manifestations; SARS-CoV-2; Subjective symptoms; COVID-19;
D O I
10.1016/j.jiph.2022.12.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Accumulating studies demonstrated that patients with coronavirus disease 2019(COVID-19) could develop a variety of neurological manifestations and long-term neurological sequelae, which may be different from the strains. At the peak of the Omicron variant outbreak in Shanghai, China, no relevant epidemiological data about neurological manifestations associated with this strain was reported.Objective: To investigate neurological manifestations and related clinical features in patients with mild to moderate COVID-19 patients with Omicron variant.Methods: A self-designed clinical information registration form was used to gather the neurological man-ifestations of mild to moderate COVID-19 patients admitted to a designated hospital in Shanghai from April 18, 2022 to June 1, 2022. Demographics, clinical presentations, laboratory findings, treatments and clinical outcomes were compared between patients with and without neurological manifestations.Results: One hundred sixty-nine(48.1 %) of 351 patients diagnosed with mild to moderate COVID-19 ex-hibited neurological manifestations, the most common of which were fatigue/weakness(25.1 %) and myalgia(20.7 %), whereas acute cerebrovascular disease(0.9 %), impaired consciousness(0.6 %) and seizure (0.6 %) were rare. Younger age(p = 0.001), female gender(p = 0.026) and without anticoagulant medication (p = 0.042) were associated with increasing proportions of neurological manifestations as revealed by multivariate logistic regressions. Patients with neurological manifestations had lower creatine kinase and myoglobin levels, as well as higher proportion of patchy shadowing on chest scan. Vaccination status, clinical classification of COVID-19 and clinical outcomes were similar between the two groups.Conclusions: Nearly half of the involved patients have neurological manifestations which were relatively subjective and closely associated with younger age, female gender and without anticoagulation. Patients with neurologic manifestations may be accompanied by increased lung patchy shadowing.(c) 2022 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:155 / 162
页数:8
相关论文
共 41 条
[1]   COVID-19 and thrombosis: From bench to bedside [J].
Ali, Mohammad A. M. ;
Spinler, Sarah A. .
TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (03) :143-160
[2]   Peripheral Nervous System Manifestations Associated with COVID-19 [J].
Andalib, Sasan ;
Biller, Jose ;
Di Napoli, Mario ;
Moghimi, Narges ;
McCullough, Louise D. ;
Rubinos, Clio A. ;
O'Hana Nobleza, Christa ;
Azarpazhooh, M. Reza ;
Catanese, Luciana ;
Elicer, Isabel ;
Jafari, Mostafa ;
Liberati, Fabrizio ;
Camejo, Claudia ;
Torbey, Michel ;
Divani, Afshin A. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (03)
[3]   Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Version) [J].
不详 .
INFECTIOUS DISEASES & IMMUNITY, 2022, 2 (03) :135-144
[4]   Anticoagulant treatment in COVID-19: a narrative review [J].
Carfora, Vincenzo ;
Spiniello, Giorgio ;
Ricciolino, Riccardo ;
Di Mauro, Marco ;
Migliaccio, Marco Giuseppe ;
Mottola, Filiberto Fausto ;
Verde, Nicoletta ;
Coppola, Nicola .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (03) :642-648
[5]   Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis [J].
Ceban, Felicia ;
Ling, Susan ;
Lui, Leanna M. W. ;
Lee, Yena ;
Gill, Hartej ;
Teopiz, Kayla M. ;
Rodrigues, Nelson B. ;
Subramaniapillai, Mehala ;
Di Vincenzo, Joshua D. ;
Cao, Bing ;
Lin, Kangguang ;
Mansur, Rodrigo B. ;
Ho, Roger C. ;
Rosenblat, Joshua D. ;
Miskowiak, Kamilla W. ;
Vinberg, Maj ;
Maletic, Vladimir ;
McIntyre, Roger S. .
BRAIN BEHAVIOR AND IMMUNITY, 2022, 101 :93-135
[6]  
Collantes MEV, 2021, CAN J NEUROL SCI, V48, P66, DOI [10.1017/cjn.2020.146, 10.1145/3334480.3382865]
[7]  
Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
[8]   Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic [J].
Dewanjee, Saikat ;
Vallamkondu, Jayalakshmi ;
Kalra, Rajkumar Singh ;
Puvvada, Nagaprasad ;
Kandimalla, Ramesh ;
Reddy, P. Hemachandra .
MOLECULAR NEUROBIOLOGY, 2021, 58 (9) :4694-4715
[9]  
Douaud G, 2022, NATURE, V604, P697, DOI [10.1038/s41586-022-04569-5, 10.1101/2021.06.11.21258690]
[10]   Neurological associations of COVID-19 [J].
Ellul, Mark A. ;
Benjamin, Laura ;
Singh, Bhagteshwar ;
Lant, Suzannah ;
Michael, Benedict Daniel ;
Easton, Ava ;
Kneen, Rachel ;
Defres, Sylviane ;
Sejvar, Jim ;
Solomon, Tom .
LANCET NEUROLOGY, 2020, 19 (09) :767-783